Indications and uses
According to homeopathic principles, the active ingredients in this medication help temporarily relieve minor symptoms such as: Blurred vision Eyestrain Tearing due to dryness
According to homeopathic principles, the active ingredients in this medication help temporarily relieve minor symptoms such as: Blurred vision Eyestrain Tearing due to dryness
Remove tamper-evident seal from neck of bottle. Twist cap off bottle. DON’T squeeze bottle, squeeze plastic tip to release 1 to 2 drops into eye. Apply every 3-4 hours, or as directed by a doctor. Replace cap after each use.
Cineraria maritima 6X
Blurred vision
Natrium muriaticum 6X
burning, reflex tearing due to dryness, eyestrain, corneal opacity, sensitivity to light
Ruta graveolens 6X
eyestrain, rednesss, eye pain when reading
According to homeopathic principles, the active ingredients in this medication help temporarily relieve minor symptoms such as:
ask a health professional before use.
If swallowed, get medical help or contact a Poison Control Center right away.
Active ingredients are manufactured according to homeopathic principles.
Borate buffer, Purified water, Silver sulphate (as preservative), Sodium nitrate
Reach our representatives at 1-800-240-9780 or getinfo@similasanusa.com.
www.SimilasanUSA.com
NDC 59262-360-11
Similasan
Aging Eye Relief
STERILE EYE DROPS
10 ml / 0.33 fl oz
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 59262-360-11 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-88a3-d83d-e063-dadaa90ab31f | Aging Eye Relief |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59262-360-11 | Aging Eye Relief | 10 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 10 | 7 | |
| 59262-360-11 | Aging Eye Relief | 1 in 1 BOX | SOLUTION/ DROPS | 1 | 7 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59262-360 | AGING EYE RELIEF (JACOBAEA MARITIMA, SODIUM CHLORIDE AND RUTA GRAVEOLENS FLOWERING TOP) SOLUTION/ DROPS [SIMILASAN CORPORATION] | 7 | Legacy NDC, 2 package rows | 20230127_a5642552-fa6a-4245-8626-6561ae0a2d5c.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59262-360-11 | ML - Milliliter | 59262-360 | b1a92b7d-3ea1-461c-a1f7-791ee056e702 | 1 | 2022-06-06 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| JACOBAEA MARITIMA | ACTIVE INGREDIENT | U4B223LS4X | 3 | |
| RUTA GRAVEOLENS FLOWERING TOP | ACTIVE INGREDIENT | N94C2U587S | 3 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 3 | |
| CHLORIDE ION | ACTIVE MOIETY | Q32ZN48698 | 3 | |
| JACOBAEA MARITIMA | ACTIVE MOIETY | U4B223LS4X | 3 | |
| RUTA GRAVEOLENS FLOWERING TOP | ACTIVE MOIETY | N94C2U587S | 3 | |
| BORIC ACID | INACTIVE INGREDIENT | R57ZHV85D4 | 3 | |
| SILVER SULFATE | INACTIVE INGREDIENT | 8QG6HV4ZPO | 3 | |
| SODIUM NITRATE | INACTIVE INGREDIENT | 8M4L3H2ZVZ | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59262-360 | 59262-360-11 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| JACOBAEA MARITIMA | U4B223LS4X | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| RUTA GRAVEOLENS FLOWERING TOP | N94C2U587S | ACTIB |
| BORIC ACID | R57ZHV85D4 | IACT |
| WATER | 059QF0KO0R | IACT |
| SILVER SULFATE | 8QG6HV4ZPO | IACT |
| SODIUM NITRATE | 8M4L3H2ZVZ | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BORIC ACID | BORIC ACID | R57ZHV85D4 | INJECTION, SOLUTION / INTRAVENOUS | 210 mg | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | GEL / OPHTHALMIC | 0.5 %w/w | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SOLUTION / OPHTHALMIC | 60 mg | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | EMULSION / OPHTHALMIC | 0.3 %w/v | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | DROPS / OPHTHALMIC | 1 %w/w | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SUSPENSION / AURICULAR (OTIC) | 0.6 %w/v | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SHAMPOO / TOPICAL | 2 %w/w | ||
| SODIUM NITRATE | SODIUM NITRATE | 8M4L3H2ZVZ | SOLUTION / OPHTHALMIC | 1.18 %w/w | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SOLUTION / AURICULAR (OTIC) | 0.05 %w/w | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 0.3 %w/w | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | EMULSION / TOPICAL | 1.3 %w/w | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | MOUTHWASH / BUCCAL | 7.36 mg/1ml | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SUSPENSION/ DROPS / TOPICAL | 0.3 %w/v | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SOLUTION/ DROPS / OPHTHALMIC | 48 mg | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 0.53 %w/v | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SUSPENSION/ DROPS / AURICULAR (OTIC) | 3 mg | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | JELLY / VAGINAL | 1 %w/w | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SUSPENSION/ DROPS / OPHTHALMIC | 22 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2c212019-a1e6-4fd0-9da9-a9d5b6e2d3f8 | a5642552-fa6a-4245-8626-6561ae0a2d5c | 2021-10-28 | Warnings | 2c212019-a1e6-4fd0-9da9-a9d5b6e2d3f8 a5642552-fa6a-4245-8626-6561ae0a2d5c |
Adverse event summaries are temporarily unavailable. Other product information remains available.